Table 3.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
|
|
|||||
Prognostic parameter | HR | 95% CI | P value | HR | 95% CI | P value |
ACP5 expression (low vs. high) | 2.228 | 1.392-3.566 | 0.001 | 2.463 | 1.533-3.957 | 0.001 |
Age (≤ 65 vs. > 65) | 1.283 | 0.817-2.016 | 0.279 | - | - | - |
Gender (male vs. female) | 0.823 | 0.521-1.300 | 0.404 | - | - | - |
Tumor Size (≤ 5 cm vs. > 5 cm) | 1.653 | 1.054-2.592 | 0.029 | 1.570 | 0.997-2.471 | 0.052 |
CEA level (≤ 5 ng/ml vs. > 5 ng/ml) | 1.465 | 0.937-2.291 | 0.093 | - | - | - |
TNM stage (I vs. II vs. III vs. IV stage) | 2.433 | 1.769-3.345 | 0.000 | 2.596 | 1.865-3.616 | 0.000 |
HR: Hazard ratio; CI: Confidence interval. The bold number represents the P-values with significant differences.